Cargando…
Metformin Protects against Podocyte Injury in Diabetic Kidney Disease
Metformin is the most commonly prescribed drug for treating type 2 diabetes mellitus (T2D). Its mechanisms of action have been under extensive investigation, revealing that it has multiple cellular targets, either direct or indirect ones, via which it regulates numerous cellular pathways. Diabetic k...
Autor principal: | Lehtonen, Sanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764076/ https://www.ncbi.nlm.nih.gov/pubmed/33321755 http://dx.doi.org/10.3390/ph13120452 |
Ejemplares similares
-
Cyclodextrin Protects Podocytes in Diabetic Kidney Disease
por: Merscher-Gomez, Sandra, et al.
Publicado: (2013) -
The Podocyte in Diabetic Kidney Disease
por: Stitt-Cavanagh, Erin, et al.
Publicado: (2009) -
SHIPping out diabetes—Metformin, an old friend among new SHIP2 inhibitors
por: Lehtonen, Sanna
Publicado: (2019) -
Editorial: Podocyte Pathology and Nephropathy—An Update
por: Lehtonen, Sanna, et al.
Publicado: (2019) -
Vitamin D/VDR Protects Against Diabetic Kidney Disease by Restoring Podocytes Autophagy
por: Song, Zhixia, et al.
Publicado: (2021)